Drug Combination May Epigenetically Help Prevent Breast Cancer
Approximately one out of every eight women in the United States will develop breast cancer at some point in their lives. Breast cancer is considered to be the most lethal cancer for women outside of lung cancer. The economic implications of breast cancer are also huge; setting aside the medical costs faced, breast cancer costs a whopping $6.2 billion in lost wages. With no surefire way to universally detect breast cancer early, it can be difficult to intervene early. Treatments must [more…]
